Cardiology – Page 3

SCAI 2022

Discordance Between Optimal Medical Therapy, Pad Risk Factors, and Major Adverse Limb Events Among Minority Patients with Peripheral Artery Disease: A Report from the PAD Go Pro Quality Program

This paper was presented on May 21 ; Day 3 of the 2022 Scientific Sessions of the Society for Cardiovascular

December 13, 2022

SCAI 2022

Minimizing Contrast Media Volume in CKD Patients Undergoing Coronary Angiography: A Real-World Quality Improvement Program

This paper was presented on May 21 ; Day 3 of the 2022 Scientific Sessions of the Society for Cardiovascular

December 12, 2022

SCAI 2022

Efficacy of Contrast Diastolic Hyperemia-Free Ratio (Contrast – DFR) in Comparison to Coronary Fractional Flow Reserve with Adenosine and Diastolic Hyperemia-Free Ratio (DFR)

This paper was presented on May 21 ; Day 3 of the 2022 Scientific Sessions of the Society for Cardiovascular

December 10, 2022

SCAI 2022

Procedural Characteristics of Patients with Ischemia and No Obstructive Disease Undergoing Invasive Coronary Physiology Testing

This paper was presented on May 21 ; Day 3 of the 2022 Scientific Sessions of the Society for Cardiovascular

December 9, 2022

SCAI 2022

Increased Anatomical and Device Detail Using a High Definition (Hi-Def) Imaging System: Elevating Precision in Complex Interventions

This paper was presented on May 21 ; Day 3 of the 2022 Scientific Sessions of the Society for Cardiovascular

December 6, 2022

SCAI 2022

SCAI PFO Closure Guideline Addresses Real-World Patient Scenarios

An expert consensus guideline created in collaboration with cardiologists, neurologists, and patients addresses decision-making about patent foramen ovale (PFO) closure

November 24, 2022

SCAI 2022

New Long-Term Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-Drug Coated Devices

New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as

November 22, 2022

SCAI 2022

Renal Denervation Increases Time in Target Range Compared to Sham Control in the Presence of Antihypertensive Drugs

This paper was presented during the orals sessions at the 2022 Scientific Sessions of the th Annual SCAI meeting on

November 21, 2022

SCAI 2022

PCI for Acute Myocardial Infarction in Patients with A Pre-Existing LVAD, Does It Improve Survival?

This paper was presented during the orals sessions at the 2022 Scientific Sessions of the Annual SCAI meeting on May

November 19, 2022

SCAI 2022

Clinical Event Reductions in Younger Vs. Older Hypertension Patients Treated with Radiofrequency Renal Denervation: 10-Year Projections Based on 3-Year Follow-Up from the Global SYMPLICITY Registry

This paper was presented during the orals sessions at the 2022 Scientific Sessions of the Annual SCAI meeting on May

November 18, 2022